Athira Pharma, Inc. (ATHA) Misses Q1 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.23), $0.05 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Electra Therapeutics files for proposed IPO
• Nomura/Instinet Starts Lenskart Solutions (LENSKART:IN) at Buy
• Jefferies Starts Schloss Bangalore Ltd (THELEELA:IN) at Buy